New York Society of Addiction Medicine

ASAM Clinical Considerations: Buprenorphine Treatment of OUD for Individuals using High-potency Synthetic Opioids

by

We’re happy to announce this publication of the American Society of Addiction Medicine Clinical Considerations: Buprenorphine Treatment of OUD for Individuals using High-potency Synthetic Opioids.

Read More

NYSAM

About NYSAM

The New York Society of Addiction Medicine is a physician-led professional community committed to the advancement of evidence-based addiction science and care. Together, we can overcome substance use disorders and the disease of addiction.View All Posts by NYSAM